Skip to main content

Bausch & Lomb Corp

BLCO
Exchange
NYSE
Industry
Ophthalmic Goods
SEC CIK
0001860742

In the last 90 days, Bausch & Lomb Corp insiders filed 0 open-market purchases and 2 sales; 99 institutions reported holding it in 13F filings for Q2 2026, worth $638.7M in total; 3 superinvestors hold it, including Icahn Capital and Oaktree Capital.

Q3 2025 vs. Q2 2025

How the institutions holding Bausch & Lomb Corp changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of BLCO: Q2 2025 compared with Q3 2025
MeasureQ2 2025Q3 2025Change
Holders9493−1
Shares38.7M39.2M+449.6K (+1.2%)
Value$504.6M$590.3M+$85.7M (+17.0%)

New holders (16)

Institutions that held Bausch & Lomb Corp at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to BLCO in Q3 2025
InstitutionSharesValue% of portfolio
Silver Point Capital L.P.2,565,000$38.7M2.01%
Davidson Kempner Capital Management LP980,474$14.8M0.21%
Maverick Capital LtdSuperinvestorMaverick Capital177,766$2.68M0.04%
Tudor Investment Corp Et Al149,270$2.25M0.01%
Trexquant Investment LP94,156$1.42M0.01%
Jane Street Group, LLC37,494$565.0K0.00%
Oxford Asset Management LLP17,822$268.6K0.09%
Mission Wealth Management, LP13,925$209.8K0.00%
Federation des caisses Desjardins du Quebec14,170$205.5K0.00%
Bridgefront Capital, LLC11,599$174.8K0.05%
Colony Group, LLC11,250$169.5K0.00%
Rockefeller Capital Management L.P.2,799$42.2K0.00%
National Bank of Canada187$2.78K0.00%
Larson Financial Group LLC157$2.37K0.00%
SRS Capital Advisors, Inc.90$1.36K0.00%
Bogart Wealth, LLC36$5430.00%

Sold out (17)

Institutions that held Bausch & Lomb Corp at the end of Q2 2025 and filed for Q3 2025 without it.